150+ Free Regis University Rueckert-Hartman College for Health Professions School of Pharmacy MMI Practice Questions

Tell me about yourself.

Why pharmacy?

Why Regis University Rueckert-Hartman College for Health Professions School of Pharmacy?

What specifically drew you to Regis University's Jesuit tradition and how does it align with your values as a future pharmacist?

Colorado has become the first state to implement prescription drug price caps, starting with Enbrel, setting the annual cost at $31,200 compared to previous insurance payments of $53,000. This groundbreaking policy aims to make medications more affordable for patients but has triggered federal lawsuits from pharmaceutical companies who argue it violates patent law and due process. Pharmacists worry about being caught between reduced reimbursements and acquisition costs. How should Colorado pharmacists navigate their professional obligation to ensure patient access to medications while managing the economic pressures created by state price controls

You are a pharmacist. A diabetic patient can't afford their $300 insulin. They've been rationing it and their blood sugar is dangerously high. What do you do?

You are a pharmacist. A prescription seems unusually high-dose. The prescriber's office is dismissive when you call to verify. The patient is in pain and waiting. What do you do?

How many rubber ducks would it take to fill this room?

Tell me about a time you failed.

How does Regis University School of Pharmacy's emphasis on serving underserved populations resonate with your career goals?

Should Colorado pharmacies be required to stock medications even when state-imposed upper payment limits create financial losses for the pharmacy

Colorado's proposed Senate Bill 71 would prevent pharmaceutical manufacturers from limiting hospitals' use of contract pharmacies in the 340B Drug Pricing Program. The state has 68 hospitals participating in 340B linked to over 1,000 pharmacies, but nearly half of contract pharmacies are located in affluent neighborhoods rather than medically underserved areas. Critics argue this allows hospitals to profit from drug discounts without demonstrating benefit to vulnerable patients. Consider the ethical implications of Colorado's approach to 340B contract pharmacy regulation when pharmacy profits may not translate to improved patient access